Cargando…
Corrigendum to: “Novel and emerging mutations of SARS-CoV-2: Biomedical implications” [Biomed. Pharmacother. 139 (2021) 111599]
Autores principales: | Mohammadi, Elmira, Shafiee, Fatemeh, Shahzamani, Kiana, Ranjbar, Mohammad Mehdi, Alibakhshi, Abbas, Ahangarzadeh, Shahrzad, Beikmohammadi, Leila, Shariati, Laleh, Hooshmandi, Soodeh, Ataei, Behrooz, HaghjooyJavanmard, Shaghayegh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Masson SAS.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123412/ https://www.ncbi.nlm.nih.gov/pubmed/34001417 http://dx.doi.org/10.1016/j.biopha.2021.111723 |
Ejemplares similares
-
Novel and emerging mutations of SARS-CoV-2: Biomedical implications
por: Mohammadi, Elmira, et al.
Publicado: (2021) -
Vaccine design and delivery approaches for COVID-19
por: Shahzamani, Kiana, et al.
Publicado: (2021) -
Comparative Analysis and Identification of Spike Mutations in Iranian COVID-19 Samples from the First Three Waves of Disease
por: Shoaei, Parisa, et al.
Publicado: (2023) -
Association of Clinical Features with Spike Glycoprotein Mutations in Iranian COVID-19 Patients
por: Ahangarzadeh, Shahrzad, et al.
Publicado: (2022) -
Current status of COVID-19 pandemic; characteristics, diagnosis, prevention, and treatment
por: Nokhodian, Zary, et al.
Publicado: (2020)